[Tolerance and schistosomicide activity of a new derivative of thiasolyl-imidazol.  Preliminary results].
D000293:Adolescent; D000328:Adult; D000349:Africa; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004339:Drug Compounding; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009560:Niridazole / Q000494:pharmacology; D009593:Nitroimidazoles / Q000494:pharmacology*; D010270:Parasite Egg Count; D012547:Schistosoma / Q000187:drug effects*; D012552:Schistosomiasis / Q000188:drug therapy*; D012556:Schistosomicides / Q000008:administration & dosage / Q000494:pharmacology*; D013844:Thiazoles / Q000494:pharmacology; D014900:West Indies
D007093:Imidazoles; D009593:Nitroimidazoles; D012556:Schistosomicides; D013844:Thiazoles; D009560:Niridazole
Tolérance et activité schistosomicide d'un nouveau dérivé thiazolyl-imidazole.  (26.354 R.P.) Résultatas préliminaires